胃黄色瘤的临床病理特征(4)
[20]张黎明，刘华，刘莉莉，等. 胃黏膜不典型增生患者的内镜随访和治疗价值分析[J]. 中国全科医学， 2013，16(9)：31263128.
[21]KHASAG O， BOLDBAATAR G， TEGSHEE T， et al. The prevalence of Helicobacter pylori infection and other risk factors among Mongolian dyspeptic patients who have a high incidence and mortality rate of gastric cancer[J]. Gut Pathog， 2018，10：14.
[21]HORI S， TSUTSUMI Y. Helicobacter pylori infection in gastric xanthomas： immunohistochemical analysis of 145 lesions[J]. Pathology International， 1996，46(8)：589593.
[22]ISOMOTO H， MIZUTA Y， INOUE K， et al. A close relationship between Helicobacter pylori infection and gastric xanthoma[J]. Scandinavian Journal of Gastroenterology， 1999，34(4)：346352.
[23]CHEN Y， HE X J， ZHOU M J， et al. Gastric xanthelasma and metabolic disorders： large retrospective study among Chinese population[J]. World J Gastroenterol， 2017，23(43)：77567764.
[24]CHOI I J， KOOK M C， KIM Y I， et al. helicobacter pylori therapy for the prevention of metachronous gastric cancer[J]. N Engl J Med， 2018，22，378(12)：10851095.
[25]YI S Y. Dyslipidemia and H pylori in gastric xanthomatosis[J]. World J Gastroenterol， 2007，13(34)：45984601.
[26]The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer[J]. Lancet， 1993，341：13591362.
[27]AIKAWA M， ISHII T， NONAKA K， et al. A case of gastic xanthogranuloma associated with early gastric cancer[J]. Nihon Shokakibyo Gakkai Zasshi， 2009，106(11)：16101615.
(本文編辑黄建乡), 百拇医药(王世杰 毛涛 田字彬)
[21]KHASAG O， BOLDBAATAR G， TEGSHEE T， et al. The prevalence of Helicobacter pylori infection and other risk factors among Mongolian dyspeptic patients who have a high incidence and mortality rate of gastric cancer[J]. Gut Pathog， 2018，10：14.
[21]HORI S， TSUTSUMI Y. Helicobacter pylori infection in gastric xanthomas： immunohistochemical analysis of 145 lesions[J]. Pathology International， 1996，46(8)：589593.
[22]ISOMOTO H， MIZUTA Y， INOUE K， et al. A close relationship between Helicobacter pylori infection and gastric xanthoma[J]. Scandinavian Journal of Gastroenterology， 1999，34(4)：346352.
[23]CHEN Y， HE X J， ZHOU M J， et al. Gastric xanthelasma and metabolic disorders： large retrospective study among Chinese population[J]. World J Gastroenterol， 2017，23(43)：77567764.
[24]CHOI I J， KOOK M C， KIM Y I， et al. helicobacter pylori therapy for the prevention of metachronous gastric cancer[J]. N Engl J Med， 2018，22，378(12)：10851095.
[25]YI S Y. Dyslipidemia and H pylori in gastric xanthomatosis[J]. World J Gastroenterol， 2007，13(34)：45984601.
[26]The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer[J]. Lancet， 1993，341：13591362.
[27]AIKAWA M， ISHII T， NONAKA K， et al. A case of gastic xanthogranuloma associated with early gastric cancer[J]. Nihon Shokakibyo Gakkai Zasshi， 2009，106(11)：16101615.
(本文編辑黄建乡), 百拇医药(王世杰 毛涛 田字彬)